UK begins trials of Ebola vaccine developed in just eight weeks

The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults. Officials and experts continue to monitor developments closely as the situation unfolds. Communities affected by the story are watching for further updates in the days ahead. Analysts say the implications could extend well beyond the immediate headlines, with policymakers and industry leaders expected to respond in the coming weeks.

Readers following this story should check back for the latest details as new information becomes available.